Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

Pharmacodynamic Models: E_max Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrated <i>In Vitro</i> and <i>In Silico</i> Profiling of Piperazinyl Thiosemicarbazone Derivatives Against <i>Trypanosoma cruzi</i>: Stage-Specific Activity and Enzyme Inhibition.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

Spatially Formed Tenacious Nickel-Supported Bimetallic Catalysts for CO<sub>2</sub> Methanation under Conventional and Induction Heating.

International journal of molecular sciences·2023

Same author

A Thiosemicarbazone Derivative as a Booster in Photodynamic Therapy-A Way to Improve the Therapeutic Effect.

International journal of molecular sciences·2022

Same author

Unsupervised Learning in Drug Design from Self-Organization to Deep Chemistry.

International journal of molecular sciences·2022

Same author

Functional and Material Properties in Nanocatalyst Design: A Data Handling and Sharing Problem.

International journal of molecular sciences·2021

Same author

Enhancing the CO<sub>2</sub> capturing ability in leaf via xenobiotic auxin uptake.

The Science of the total environment·2020

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Receptor dependent multidimensional QSAR for modeling drug--receptor interactions.

Jaroslaw Polanski¹

¹Institute of Chemistry, University of Silesia, Katowice, Poland. polanski@us.edu.pl

Current Medicinal Chemistry

|June 25, 2009

Summary

Quantitative Structure Activity Relationship (QSAR) modeling has evolved significantly, moving from 2D to 3D structures. Incorporating receptor data in receptor-dependent QSAR (RD QSAR) improves prediction accuracy for complex biological interactions.

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Experiment Videos

Last Updated: Jun 22, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Area of Science:

* Cheminformatics
* Computational Chemistry
* Drug Discovery

Background:

* Quantitative Structure Activity Relationship (QSAR) traditionally maps chemical structures to properties using methods like Hansch analysis.
* Recent advancements focus on 3D molecular descriptors, conformational dynamics, and solvation, acknowledging the complexity of biological systems.
* In silico simulations of molecular interactions often yield noisy data, highlighting limitations in traditional receptor-independent (RI) QSAR.

Purpose of the Study:

* To address the limitations of RI m-QSAR by exploring the integration of receptor data.
* To propose a systematic classification for multi-dimensional QSAR (m-QSAR) methods.
* To enhance the accuracy of activity modeling and predictions in drug discovery.

Main Methods:

* Review and analysis of the evolution of QSAR methodologies.
* Exploration of receptor-dependent (RD) QSAR approaches.
* Development of a novel classification system for m-QSAR based on data dimensionality (3D to 7D).

Main Results:

* Demonstrated the necessity of receptor data to overcome molecular recognition uncertainty in QSAR.
* Identified limitations in traditional RI m-QSAR for modeling complex ligand-receptor interactions.
* Proposed a new systematic classification for m-QSAR, ranging from 3D ligand representation to 7D receptor-based models.

Conclusions:

* Receptor-dependent QSAR (RD QSAR) is crucial for accurate modeling of complex biological interactions.
* Advances in computational power facilitate the development of sophisticated RD QSAR methods.
* A clear, dimension-based classification (3D-7D) provides a framework for understanding and developing advanced m-QSAR approaches.